{
    "2019-02-26": [
        [
            {
                "time": "2018-01-03",
                "original_text": "What Wall Street Recommends for Amarin and Novavax",
                "features": {
                    "keywords": [
                        "Wall Street",
                        "Amarin",
                        "Novavax"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Biotech ETFs Jump on Roche-Spark Deal",
                "features": {
                    "keywords": [
                        "Biotech ETFs",
                        "Roche",
                        "Spark",
                        "Deal"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Alkermes' (ALKS) and Biogen's NDA for BIIB098 Accepted by FDA",
                "features": {
                    "keywords": [
                        "Alkermes",
                        "ALKS",
                        "Biogen",
                        "NDA",
                        "BIIB098",
                        "FDA"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Xencor Inc (XNCR) Q4 2018 Earnings Conference Call Transcript",
                "features": {
                    "keywords": [
                        "Xencor",
                        "XNCR",
                        "Q4 2018",
                        "Earnings",
                        "Conference Call"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}